Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

RNA interference and antiviral therapy.

Yan Ma1, Chu-Yan Chan, Ming-Liang He

  • 1Stanley Ho Centre for Emerging Infectious Diseases, and Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, NT, Hong Kong, China.

World Journal of Gastroenterology
|September 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NAT10 Increases Lysosomal Acidification to Promote Esophageal Cancer Metastasis via ac4C Acetylation of ATP6V0E1 mRNA.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

PIM1 Attenuates Innate Immunity to Foster Coronavirus Replication through Ubiquitin Ligase β-TrCP-Mediated IFNAR1 Degradation.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

Carbon Quantum Dots Assisted Virus Tracking: From Skin to Brain.

Advanced materials (Deerfield Beach, Fla.)·2025
Same author

LIMK1 as a Novel Kinase of β-Catenin Promotes Esophageal Cancer Metastasis by Cooperating With CDK5.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

Targeting WDPF domain of Hsp27 achieves a broad spectrum of antiviral.

MedComm·2025
Same author

Erp57 facilitates ZIKV-induced DNA damage via NS2B/NS3 complex formation.

Emerging microbes & infections·2024
Same journal

Lessons from extended induction and practical evidence for improving tofacitinib therapy in ulcerative colitis.

World journal of gastroenterology·2026
Same journal

Small animal <i>ex vivo</i> machine perfusion of the liver: A comprehensive literature review.

World journal of gastroenterology·2026
Same journal

Comparable remission and health care use in real-world inflammatory bowel disease patients initiating originator biologics <i>vs</i> biosimilars.

World journal of gastroenterology·2026
Same journal

Diagnosis and management of metabolic dysfunction-associated steatohepatitis in patients with chronic hepatitis B infection.

World journal of gastroenterology·2026
Same journal

Simultaneous treatment of concomitant achalasia coexisting with epiphrenic diverticulum: The practice of submucosal tunneling technique.

World journal of gastroenterology·2026
Same journal

Lianhe Xiaozhi ointment ameliorates metabolic dysfunction-associated steatotic liver disease <i>via</i> peroxisome proliferator-activated receptor alpha pathway activation.

World journal of gastroenterology·2026
See all related articles

RNA interference (RNAi) is a gene silencing mechanism utilizing short RNA molecules. This review explores RNAi

Area of Science:

  • Molecular Biology
  • Genetics
  • Virology

Background:

  • RNA interference (RNAi) is an evolutionarily conserved gene silencing mechanism in eukaryotes.
  • It employs short double-stranded RNA (dsRNA) to target and degrade or repress homologous RNA.
  • RNAi can be induced via small interfering RNAs (siRNAs) or short hairpin RNA (shRNA) expression.

Purpose of the Study:

  • To review recent advancements in using RNAi for viral infection prevention and treatment.
  • To discuss the mechanisms, strategies, challenges, and future prospects of RNAi in the pharmaceutical industry.

Main Methods:

  • Review of current literature on RNAi applications in virology.
  • Analysis of RNAi delivery systems (non-viral and viral vectors).
  • Discussion of therapeutic strategies and challenges.

Related Experiment Videos

Main Results:

  • RNAi is a potent tool for functional genomics and has therapeutic potential for diseases like cancer and viral infections.
  • Recent developments show promise in applying RNAi for managing viral diseases.
  • Various strategies exist for inducing RNAi in vitro and in vivo.

Conclusions:

  • RNAi offers a sequence-specific gene silencing approach with significant potential in treating viral infections.
  • Overcoming hurdles in delivery and stability is key for pharmaceutical applications.
  • Continued research is crucial for realizing the full therapeutic promise of RNAi.